ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.147,85
-0,54%
S&P 500
5.721,10
-0,13%
Dow Jones
41.819,30
-0,55%
Euro vs US Dollar
1,08811
0,07%
Bitcoin
67.937,12
-1,17%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC

  6. Daiichi Sankyo Co Ltd (PK) (DSKYF) Börsenkurse

Daiichi Sankyo Co Ltd (PK)

Daiichi Sankyo Co Ltd (PK) (DSKYF)

USOTC
33,55
1,43
( 4,44% )
Aktualisiert: 19:14:33
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
33,55
Gebot
32,00
Fragen
33,55
Volumen
3.222
32,00 Tagesbereich 33,55
25,72 52-Wochen-Bereich 44,64
Marktkapitalisierung
64,308B
Handelsende
32,125
Handelsbeginn
32,16
Letzte Trade
76
@
32.2
Letzter Handelszeitpunkt
20:11:09
Finanzvolumen
US$ 105.601
VWAP
32,775
Durchschnittliches Volumen (3 Mio.)
2.946
Ausgegebene Aktien
1.916.787.029
Dividendenrendite
15,870.28%
Kurs-Gewinn-Verhältnis
0,32
Gewinn pro Aktie (EPS)
104,72
Erlöse
1,63T
Nettogewinn
200,73B

Über Daiichi Sankyo Co Ltd (PK)

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Biolog/vaccines
Website
www.daiichisankyo.co.jp
Hauptsitz
Chuo, Tokyo, Jpn
Gegründet
2005
Daiichi Sankyo Co Ltd (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker DSKYF. The last closing price for Daiichi Sankyo (PK) was US$32,13. Over the last year, Daiichi Sankyo (PK) shares have traded in a share price range of US$ 25,72 to US$ 44,64.

Daiichi Sankyo (PK) currently has 1.916.787.029 shares in issue. The market capitalisation of Daiichi Sankyo (PK) is US$61,58 billion. Daiichi Sankyo (PK) has a price to earnings ratio (PE ratio) of 0.32.

DSKYF Neueste Nachrichten

Weitere Nachrichten

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...

15 April 2015
PR Newswire (US)

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...

01 April 2015
PR Newswire (US)

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources PR Newswire PARSIPPANY, N.J., June 28, 2011 PARSIPPANY, N.J., June 28, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc...

28 Juni 2011
PR Newswire (US)

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc. PR Newswire PARSIPPANY, N.J., April 4, 2011 PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced...

04 April 2011
PR Newswire (US)

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fib

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest...

01 Dezember 2010
PR Newswire (US)

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillatio

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest Clinical...

01 Dezember 2010
PR Newswire (US)

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology PR Newswire WOBURN, Massachusetts, October 12, 2010 WOBURN, Massachusetts, October 12, 2010 /PRNewswire/ -- ArQule, Inc...

12 Oktober 2010
PR Newswire (US)

Patients with Hypertension at Risk Due to Physician Inertia

Patients with Hypertension at Risk Due to Physician Inertia - New Supporting Hypertension Awareness and Research Europe-wide (SHARE) Survey Reports Findings at the 20th Annual Society of the...

21 Juni 2010
PR Newswire (US)

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban - Innovative Once-Daily Oral Factor Xa Inhibitor Submitted for Approval in Japan PR Newswire TOKYO, April...

06 April 2010
PR Newswire (US)

Daiichi Sankyo, Inc. Names Dr. Jay Feingold Vice President, Medical Affairs

Bolsters Company's Expertise in Areas of Oncology and Hematology PARSIPPANY, N.J., Feb. 11 /PRNewswire-FirstCall/ -- Daiichi Sankyo, Inc. (DSI) announced today that Jay M. Feingold, M.D., Ph.D...

11 Februar 2010
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.210.62987402519533.3434.630.5265131.4794172CS
41.444.4845842416732.1135.3930.1309432.75605182CS
12-3.45-9.324324324323744.6430.1294635.9250008CS
26-3.42-9.2507438463636.9744.6430.1616334.91738336CS
525.7720.770338372927.7844.6425.721018031.58711919CS
1569.0236.771300448424.5344.6419.45797430.14156161CS
260-29.35-46.661367249662.995.9617.61616830.10835337CS

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MNGGMining Global Inc (PK)
US$ 0,0001
(9.900,00%)
30k
ONCIOn4 Communications Inc (PK)
US$ 0,0001
(9.900,00%)
550k
CBGLCannabis Global Inc (PK)
US$ 0,0001
(9.900,00%)
6,96M
MPXOFMPX International Corporation (CE)
US$ 0,0001
(9.900,00%)
111,77k
GKINGuskin Gold Corporation (CE)
US$ 0,0001
(9.900,00%)
630
RRMLFRoss River Minerals Inc (CE)
US$ 0,000001
(-99,99%)
150
UNMKTritent International Agriculture Inc (CE)
US$ 0,000001
(-99,99%)
405
GIGAQGiga Tronics Inc (CE)
US$ 0,000001
(-99,99%)
8,81k
PTAUFPort Of Tauranga Ltd (PK)
US$ 0,0008
(-99,98%)
9,6k
LLBOLifeline Biotech Inc (CE)
US$ 0,000001
(-99,86%)
2,38M
ASIIAccredited Solutions Inc (PK)
US$ 0,0005
(-44,44%)
515,29M
AURIAuri Inc New (PK)
US$ 0,0001
(-33,33%)
280,9M
RDARRaadr Inc (PK)
US$ 0,00095
(-5,00%)
127,56M
PHILPHI Group Inc (PK)
US$ 0,0002
(-33,33%)
111,31M
NSAVNet Savings Link Inc (PK)
US$ 0,00065
(8,33%)
108,6M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

USOTC
DSKYF
Daiichi Sankyo (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten